Lifevantage (NASDAQ:LFVN) Share Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened

Lifevantage Corporation (NASDAQ:LFVN) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.72 and traded as high as $6.34. Lifevantage shares last traded at $6.20, with a volume of 89,958 shares.

Analysts Set New Price Targets

A number of brokerages have issued reports on LFVN. Lake Street Capital cut Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 target price for the company. in a report on Thursday, May 7th. Weiss Ratings raised Lifevantage from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, May 26th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $5.00.

Lifevantage Stock Performance

The company has a fifty day simple moving average of $6.78 and a 200 day simple moving average of $5.72. The stock has a market capitalization of $78.24 million, a price-to-earnings ratio of 13.78 and a beta of 0.73.

Lifevantage (NASDAQ:LFVN) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.04). The company had revenue of $43.72 million during the quarter, compared to analyst estimates of $47.77 million. Lifevantage had a net margin of 2.94% and a return on equity of 23.89%. As a group, equities analysts predict that Lifevantage Corporation will post 0.6 earnings per share for the current fiscal year.

Lifevantage Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 3.2%. The ex-dividend date was Monday, June 1st. This is a positive change from Lifevantage’s previous quarterly dividend of $0.04. Lifevantage’s dividend payout ratio (DPR) is 44.44%.

Institutional Investors Weigh In On Lifevantage

A number of institutional investors have recently modified their holdings of LFVN. DGS Capital Management LLC bought a new position in Lifevantage during the first quarter worth $44,000. Hsbc Holdings PLC bought a new stake in Lifevantage during the first quarter valued at $51,000. JPMorgan Chase & Co. grew its holdings in Lifevantage by 870.2% during the 2nd quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company’s stock worth $66,000 after acquiring an additional 4,499 shares during the period. Franklin Resources Inc. acquired a new stake in Lifevantage during the 4th quarter worth about $74,000. Finally, Aristides Capital LLC bought a new position in shares of Lifevantage in the 4th quarter worth about $76,000. 35.32% of the stock is owned by institutional investors.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.